Creative Capital Management Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$158K Buy
5,614
+3,103
+124% +$82.6K 0.05% 71
2025
Q4
$62.5K Hold
2,511
0.02% 104
2025
Q3
$64K Sell
2,511
-37
-1% -$913 0.02% 102
2025
Q2
$61.8K Buy
2,548
+37
+1% +$863 0.02% 104
2025
Q1
$63.6K Hold
2,511
0.02% 96
2024
Q4
$66.6K Hold
2,511
0.03% 90
2024
Q3
$72.7K Hold
2,511
0.03% 84
2024
Q2
$70.3K Sell
2,511
-477
-16% -$13.1K 0.03% 77
2024
Q1
$82.9K Hold
2,988
0.04% 68
2023
Q4
$86K Buy
2,988
+692
+30% +$20.9K 0.05% 64
2023
Q3
$76.2K Sell
2,296
-140
-6% -$4.95K 0.05% 70
2023
Q2
$89.4K Hold
2,436
0.06% 62
2023
Q1
$99.4K Buy
2,436
+201
+9% +$8.68K 0.07% 67
2022
Q4
$115K Buy
+2,235
New +$107K 0.1% 52

Other funds holding PFE

Creative Capital Management Investments's PFE Position: Q1 2026 in Review

Creative Capital Management Investments increased its Pfizer (PFE) stake by 124% in Q1 2026, buying an estimated $82.6K and bringing the position to 5,614 shares worth $158K. The position accounts for 0.05% of the portfolio, ranked #71.

Creative Capital Management Investments first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Creative Capital Management Investments held 5,614 shares of Pfizer worth $158K as of Q1 2026.
  • Creative Capital Management Investments bought 3,103 Pfizer shares in Q1 2026, an estimated $82.6K.
  • Pfizer made up 0.05% of Creative Capital Management Investments's portfolio in Q1 2026, its #71 holding.
  • Creative Capital Management Investments first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Creative Capital Management Investments's 13F filing for Q1 2026, filed 21 Apr 2026.